Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
08/2010
08/18/2010CN101805358A Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in treatment of type 2 diabetes
08/18/2010CN101805326A 1,3-diaryl-3-aromatic amino-1-propanol compound and preparation method and application thereof
08/18/2010CN101805325A Novel lignan compound and application thereof
08/18/2010CN101805247A Fluorine marking cyclofenil derivative as well as reference compound, midbody, preparation method and application thereof
08/17/2010US7776820 Methods for decreasing risk of complications of prematurity using IGF-I and its analogs
08/17/2010CA2471762C Cell-permeable peptide inhibitors of the jnk signal transduction pathway
08/17/2010CA2444980C Single dose aromatase inhibitor for treating infertility
08/17/2010CA2382940C 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands
08/12/2010WO2009082437A9 Selective androgen receptor modulators (sarms) and uses thereof
08/12/2010US20100204332 Method for treating a disease or condition responsive to opening of c1c-2 channel
08/12/2010US20100204258 Methods and compositions for modulating insulin secretion and glucose metabolism
08/12/2010US20100204250 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
08/12/2010US20100204228 Aryl Sulfonamides Useful for Modulation of the Progesterone Receptor
08/12/2010US20100204213 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
08/12/2010US20100204189 Methods and Compounds for Vitamin D Therapy
08/12/2010US20100204188 Method of synergistically enhancing the therapeutic efficacy and safety of medications through a combination therapy
08/12/2010US20100203143 Systems and methods for nanomagnetic actuation of molecular cell signaling
08/12/2010US20100203016 Pregnancy hormone combination for treatment of autoimmune diseases
08/11/2010EP2216409A1 Albumin fusion proteins
08/11/2010EP2216330A1 Oxadiazolidinedione compound
08/11/2010EP2215268A1 Adiponectin receptor fragments and methods of use
08/11/2010EP2215090A1 Purine derivatives useful as pi3 kinase inhibitors
08/11/2010CN101801960A prodrugs to thyroid hormone analogs
08/11/2010CN101801388A Transdermally absorbable preparation
08/11/2010CN101801375A Insulin sensitisers and methods of treatment
08/11/2010CN101797265A Application of belamcanda chinensis total isoflavone or isoflavone compounds in preparing medicaments and food for preventing and treating women's disease
08/10/2010US7772218 Synthesis of steroids, especially 3-hydroxy-7 alpha -methyl-21-[2'-methoxy-4'-(diethylaminomethyl)-phenoxy]-19-norpregna-1,3,5(10)triene citrate and treatment of prostate disorders such as prostatic cancer.
08/10/2010US7772001 Determining preferential gene expression pattern in embryonic cells; obtain cells, monitor gene expresion products, incubate with animal growth regulators, monitor gene expresion pattern and differentiation in cells
08/10/2010US7771744 Bazedoxifene acetate formulations
08/10/2010US7771739 Implantable medical devices comprising semi-crystalline poly(ester-amide)
08/10/2010CA2488592C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/10/2010CA2444506C Orodispersible effervescent tablets
08/10/2010CA2250309C Steroids as neurochemical initiators of change in human blood levels of lh or fsh
08/10/2010CA2243235C Immunotherapy using cytotoxic t lymphocytes (ctl)
08/05/2010WO2010088574A1 Azabenzimidazoles and related analogs as sirtuin modulators
08/05/2010WO2010088450A2 Methods for treating diseases associated with the modulation of serca
08/05/2010WO2010086972A1 Antistress agent
08/05/2010WO2010086129A1 Inclusion complex comprising cinacalcet and cyclodextrin
08/05/2010WO2010068500A3 PROGESTATIONAL 3-(6,6-ETHYLENE-17b-HYDROXY-3-OXO-17a-PREGNA-4-ENE-17a -YL) PROPIONIC ACID g-LACTONES
08/05/2010US20100197790 Container for pharmaceutical use for the quantitative release of a single dose for oral administration of t3 and t4 thyroid hormones in solution
08/05/2010US20100197658 Pharmaceutical use of fused 1,2,4-triazoles
08/05/2010US20100197645 Thioamide Derivatives as Progesterone Receptor Modulators
08/05/2010US20100197589 Modified growth hormone polypeptides
08/05/2010US20100197582 Growth hormone fusion proteins
08/05/2010US20100197573 Transglutaminase Mediated Conjugation of Growth Hormone
08/05/2010US20100196477 Dry Mouldable drug formulation
08/05/2010US20100196399 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
08/05/2010US20100196276 diagnosing hypothyroidism in a canine via measuring thyroxine levels, administering sialylated recombinant Thyroid Stimulating Hormone (produced by isolated lepidopteran cell), comparing thyroxine levels thereafter; cost efficiency
08/04/2010EP2213743A1 Albumin fusion proteins
08/04/2010EP2212314A1 Imidazolidine-2,4-dione (hydantoin) derivatives useful as npy y2 receptor modulators
08/04/2010EP2212285A1 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors
08/04/2010EP1638947B1 Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1
08/04/2010CN101796018A (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
08/04/2010CN101796017A (carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
08/04/2010CN101795698A Composition for prevention or treatment of disease associated with the production of autoantibody
08/04/2010CN101795680A excipients for protein stabilization
08/04/2010CN101791368A Edible fungi combined polysaccharide health-care capsule for males
08/03/2010US7767679 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/03/2010US7767676 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy
08/03/2010US7767207 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders
08/03/2010CA2459311C 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
08/03/2010CA2455064C Transdermal therapeutic system based on polyacrylate contact adhesives without functional groups
08/03/2010CA2444269C Treatment of disorders secondary to organic impairments
08/03/2010CA2306343C Novel aryloxy-alkyl-dialkylamines
07/2010
07/29/2010WO2010085145A1 Method for the prophylaxis or treatment of flushing
07/29/2010WO2010084999A1 Immunosuppressive agents and prophylactic and therapeutic agents for autoimmune diseases
07/29/2010WO2010084120A1 N-oxides of 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives useful as nicotinic acetylcholine receptor ligands
07/29/2010US20100190829 Renin inhibitors
07/29/2010US20100190769 Thiazolopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase
07/29/2010US20100190758 Progesterone Antagonist and Selective Progesterone Modulator in the Treatment of Excessive Uterine Bleeding
07/29/2010US20100189819 Neuro-degenerative inhibitor, neuro-endocrine modulator, and neuro-cerebral metabolism enhancer
07/29/2010US20100189789 Micronized Tanaproget, Compositions, and Methods of Preparing the Same
07/29/2010US20100189686 Albumin Fusion Proteins
07/29/2010CA2750582A1 Method for the prophylaxis or treatment of flushing
07/28/2010EP2210880A1 Benzoxazinone derivative
07/28/2010EP1545560B1 Compositions for inhibiting protein kinase c alpha for the treatment of diabetes mellitus
07/28/2010EP1458392B9 Acridones as inhibitors of impdh enzyme
07/28/2010CN101790376A Tsh receptor antagonizing tetrahydroquinoline compounds
07/28/2010CN101786953A Kaurane-type diterpenoid compound as well as preparation method and medical application thereof
07/28/2010CN101785775A Pharmaceutical application of 15- or 16- substituted testosterone analogues
07/28/2010CN101007085B A drug for treating hyperthyroidism and its preparation method
07/27/2010US7763747 Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; Alzheimer's disease; diabetes; A beta amyloidosis
07/27/2010US7763662 reducing weight in mammals; Substituted with a thio, sulfoxy or sulfonyl group eg 5-Chloro-2-methylsulfonylindan-1-ol, 5-Chloro-2-(propane-2-sulfonyl)indan-1-ol, 5-Chloro-2-ethanesulfonylindan-1-ol
07/27/2010US7763284 Method for treating or preventing symptoms associated with menopause
07/27/2010CA2470105C Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents
07/27/2010CA2373797C Methods of treating or preventing affective disorders
07/22/2010WO2010083034A1 Methods for increasing adiponectin
07/22/2010US20100184772 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators
07/22/2010US20100184739 Modulators of ATP-Binding Cassette Transporters
07/22/2010US20100184689 Pharmaceutical Composition Containing Botulinum Neurotoxin
07/22/2010US20100184688 Compositions and methods for enhanced mucosal delivery of parathyroid hormone
07/22/2010US20100183624 Methods for increasing adiponectin
07/22/2010CA2749544A1 Methods for increasing adiponectin
07/21/2010EP2207788A1 Steroidal [3, 2-c]pyrazole compounds, with glucocorticoid activity
07/21/2010CN1845723B Methods for the treatment of endometriosis
07/21/2010CN101784528A Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof
07/21/2010CN101780268A Method and reagent for diagnosing, preventing and treating insulin resistance
07/21/2010CN101780242A Health or medicine composite and preparation method and application thereof
07/20/2010US7759355 administering a xanthine derivative such as (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine
07/20/2010US7759330 21-substituted progesterone derivatives as new antiprogestational agents
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 290